San Diego, CA, United States of America

Maxim Ratnikov

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maxim Ratnikov. Retrieved from https://idiyas.com/inventor/maxim-ratnikov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maxim Ratnikov - Innovator in Pharmaceutical Compounds

Introduction

Maxim Ratnikov is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating parasitic diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Maxim Ratnikov holds a patent for "5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases." This invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof. It also includes a method for manufacturing the compounds and outlines their therapeutic uses. Furthermore, the invention presents a combination of pharmacologically active agents and a pharmaceutical composition.

Career Highlights

Maxim Ratnikov is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Jan Jiricek and Isabelle K Lerario. Their collaboration fosters an environment of innovation and shared knowledge, enhancing the potential for impactful discoveries in the pharmaceutical industry.

Conclusion

Maxim Ratnikov's work exemplifies the spirit of innovation in the pharmaceutical sector. His contributions, particularly in the treatment of parasitic diseases, highlight the importance of research and development in improving public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…